SAGA DIAGNOSTICS

Serial Number 79296383
Registration 6504579
700

Registration Progress

Application Filed
Mar 5, 2020
Under Examination
Approved for Publication
Jul 20, 2021
Published for Opposition
Jul 20, 2021
Registered
Oct 5, 2021

Trademark Image

SAGA DIAGNOSTICS

Basic Information

Serial Number
79296383
Registration Number
6504579
Filing Date
March 5, 2020
Registration Date
October 5, 2021
Published for Opposition
July 20, 2021
Drawing Code
5000

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 5, 2021
Registration
Registered
Classes
005 042 044

Rights Holder

SAGA Diagnostics AB

99
Address
Medicon Village,
Scheelevägen 2 SE-223 81 Lund
SE

Ownership History

SAGA Diagnostics AB

Original Applicant
99
SE

SAGA Diagnostics AB

Owner at Publication
99
SE

SAGA Diagnostics AB

Original Registrant
99
SE

Legal Representation

Attorney
Sarah J. Schneider

USPTO Deadlines

Next Deadline
796 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-10-05)
Due Date
October 05, 2027
Grace Period Ends
April 05, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

47 events
Date Code Type Description Documents
Jul 24, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Dec 15, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 15, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 15, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 15, 2022 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Dec 15, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 15, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 18, 2022 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Mar 24, 2022 FIMP P FINAL DISPOSITION PROCESSED Loading...
Mar 24, 2022 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jan 21, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jan 5, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Oct 5, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 20, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 20, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 19, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jun 30, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 30, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jun 30, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jun 14, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 14, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 14, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 14, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 14, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 1, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
Jun 1, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
Jun 1, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
May 1, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 30, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 30, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 4, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
Dec 11, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Dec 11, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Nov 26, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Nov 25, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 24, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 19, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 19, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 19, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 19, 2020 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Nov 19, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 19, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 18, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 18, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 18, 2020 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Nov 13, 2020 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 22, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; chemical preparations for use in DNA analysis for medical purposes; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the prevention of tumours; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating malignant tumors; nucleic acid sequences for medical and veterinary purposes; medical diagnostic reagents and assays for testing of body fluids; clinical medical reagents; veterinary diagnostic reagents; medical diagnostic reagents; reagents for medical use; chemical reagents for veterinary use; chemical reagents for medical use; reagents for microbiological analysis for veterinary use; reagents for microbiological analysis for medical use; diagnostic reagents for medical use; diagnostic reagents for medicinal use; immunoassay reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; chemical diagnostic reagents for medical use; reagents for analytical purposes for medical purposes; reagents for blood grouping for medical purposes; reagents for microbiological analysis for medical purposes; reagents for analytical purposes for veterinary purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic pregnancy tests; chemical reagents for medical or veterinary purposes; reagents for use in analysis for veterinary purposes; reagents for use in analysis for medical purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for in-vitro laboratory use for medical purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for in-vitro laboratory use for veterinary purposes; genetic identity tests comprised of reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids; reagents for use in veterinary genetic testing; genetic identity tests comprised of reagents for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Scientific research for medical purposes in the area of cancerous diseases; scientific laboratory services, laboratory research services relating to detection of sequence variants in DNA or RNA; laboratory testing services relating to detection of sequence variants in DNA or RNA; analytical medical laboratory services; analytical veterinary laboratory services; scientific laboratory services; medical laboratory services; veterinary laboratory services; medical chemical laboratory services; medical biological laboratory services; medical research laboratory services; medical chemical research laboratory services; medical biological research laboratory services; medical laboratory services for analytical testing; medical services of a chemical laboratory; DNA testing services to determine paternity laboratory services; laboratory research services relating to dermatology; laboratory research services relating to pharmaceuticals; medical services of a chemical and/or biological laboratory; medical laboratory services relating to the production of monoclonal antibodies; DNA screening for scientific research purposes; clinical trials for others; conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; conducting clinical trials in the field of cardiovascular disease for others; conducting clinical trials in the field of acupuncture therapy for others; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical research in the field of cancer and infectious diseases; biological research, clinical research and medical research; basic and clinical research in the field of respiratory science and medicine; pharmaceutical research services; research on the subject of pharmaceuticals; pharmaceutical research and development; research relating to pharmaceuticals; pharmaceutical research and development services; laboratory research services relating to pharmaceuticals; research on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; research and development for the pharmaceutical industry; consultancy in the field of pharmaceutical research; research and development in the pharmaceutical and biotechnology fields; scientific research, namely, genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; genetic testing for scientific research purposes; scientific research, namely, genetic engineering services relating to plants; medical research in the field of gene therapy; scientific research relating to genetics of plants; laboratory research in the field of gene expression; genetic testing of laboratory animals for research purposes
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
Lung cancer screening services; prostate cancer screening services; breast cancer screening services; bowel cancer screening services; cervical cancer screening services; providing cancer screening services; testicular cancer screening services; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; RNA or DNA analysis for cancer diagnosis and prognosis provided by medical laboratories; genetic testing of animals for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes; DNA screening for medical purposes; drug, alcohol and DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; medical and health services relating to DNA, genetics and genetic testing; genetic counseling; genetic testing of animals for diagnostic or treatment purposes; genetic testing for medical purposes; genetic testing of animals for diagnostic or treatment purposes
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of "SAGA" in black capital letters with the left bar of each letter "A" composed of one indigo and one red rectangle. Below it the word "DIAGNOSTICS" appears in smaller black capital letters.
Color Claim
The color(s) black, red, and indigo is/are claimed as a feature of the mark.

Classification

International Classes
005 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"DIAGNOSTICS"